Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer
142 DCE-MRI radiogenomics predicts immune microenvironment subtypes and neoadjuvant chemotherapy response in HR+/HER2− breast cancer
- 15 Department of Breast Surgery, Fujian Cancer Hospital, Fuzhou, China
- 2Department of Breast Surgery, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, China
Related
- Relative change rate of neutrophil-to-albumin ratio (ΔNAR) during neoadjuvant chemotherapy predicts axillary pathological complete response in locally advanced breast cancer
- Mammography based delta radiomics with machine learning predicts pathologic complete response after neoadjuvant chemotherapy in breast cancer
- Impact of neoadjuvant chemotherapy on the association between key genetic alterations and tumor microenvironment in upper tract urothelial carcinoma
- Skeletal muscle depletion during neoadjuvant chemoimmunotherapy predicts postoperative complications in non-small cell lung cancer: a retrospective cohort study
- Neoadjuvant chemotherapy in locally advanced colon cancer: lessons from the NeoCol trial and the limits of anatomical risk stratification.
BibTeX
@article{song2026dcemri,
title = {{142 DCE-MRI radiogenomics predicts immune microenvironment subtypes and neoadjuvant chemotherapy response in HR+/HER2− breast cancer}},
author = {Chuangui Song and Yushuai Yu and Ruiliang Chen},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2026},
month = nov,
doi = {10.1136/jitc-2026-sitc2026.0142},
url = {https://doi.org/10.1136/jitc-2026-sitc2026.0142},
note = {CC BY},
}
RIS
TY - JOUR
TI - 142 DCE-MRI radiogenomics predicts immune microenvironment subtypes and neoadjuvant chemotherapy response in HR+/HER2− breast cancer
AU - Chuangui Song
AU - Yushuai Yu
AU - Ruiliang Chen
PY - 2026
DA - 2026/11/06
JO - Journal for ImmunoTherapy of Cancer
DO - 10.1136/jitc-2026-sitc2026.0142
UR - https://doi.org/10.1136/jitc-2026-sitc2026.0142
SN - 2051-1426
ER -